This Article Full Text Full Text (PDF) All Versions of this Article: 109/19/2309    most recent 01.CIR.0000129269.98460.C8v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schaverien, M. V. Articles by McCrindle, B. W. Search for Related Content PubMed PubMed Citation Articles by Schaverien, M. V. Articles by McCrindle, B. W. Related Collections CV surgery: valvular disease Pediatric and congenital heart disease, including cardiovascular surgery

(Circulation. 2004;109:2309-2313.)
© 2004 American Heart Association, Inc.

Clinical Investigation and Reports

Independent Factors Associated With Outcomes of Parachute Mitral Valve in 84 Patients

From the Division of Cardiology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

Correspondence to Dr Brian McCrindle, The Hospital for Sick Children, 555 University Ave, Toronto, Ontario, Canada M5G 1X8. E-mail brian.mccrindle{at}sickkids.ca

Received October 3, 2003; revision received February 5, 2004; accepted February 6, 2004.

Background— Parachute mitral valve (PMV) is defined as a unifocal attachment of the mitral valve chordae to a single or dominant papillary muscle and may cause subvalvar obstruction. We sought to determine factors associated with outcomes.

Methods and Results— Patients (n=84; 64% male) who presented between 1977 and 2001 at a median age of 3 days (range, birth to 5.4 years) were assessed with PMV (without atrioventricular septal defect). Associated cardiac anomalies in 99% included aortic coarctation in 68%, atrial septal defect in 54%, ventricular septal defect in 46%, aortic valve stenosis in 32%, subaortic stenosis in 20%, and left ventricular hypoplasia in 19%, with complex anomalies in 14%. Noncardiac anomalies were noted in 32%. Survival (n=18 deaths) was 82% at 1 year and 79% at 10 years, with independent risk factors including left ventricular hypoplasia (P<0.001) and atrial septal defect (P<0.003). Freedom from surgical mitral valvotomy (n=11 patients) was 95% at age 6 months and 80% at 10 years, with independent risk factors including the absence of aortic coarctation (P<0.02) and the presence of subaortic stenosis (P<0.04). There was no significant increase in mean gradient of the PMV over time, but higher gradient was independently associated with the presence of supravalvar mitral stenosis (P<0.001), absence of atrial septal defect (P<0.04), presence of ventricular septal defect (P<0.02), and subsequent mitral valvotomy (P<0.01).

Conclusions— Outcomes for patients with PMV are dependent on the spectrum of associated cardiac lesions. The degree of mitral valve obstruction remains stable, and the majority will not require valvotomy.

Key Words: mitral valve • stenosis • heart defects, congenital • pediatrics • prognosis

This article has been cited by other articles:

				G. Agnoletti, O. Raisky, Y. Boudjemline, P. Ou, D. Bonnet, D. Sidi, and P. Vouhe Neonatal Surgical Aortic Commissurotomy: Predictors of Outcome and Long-Term Results Ann. Thorac. Surg., November 1, 2006; 82(5): 1585 - 1592. [Abstract] [Full Text] [PDF]

				B. Fitzsimons and C. G. Koch Parachute Mitral Valve Anesth. Analg., December 1, 2005; 101(6): 1613 - 1614. [Full Text] [PDF]